- Investing Ideas
- Global Pharmaceuticals & Biotech Breakout Stocks
Global Pharmaceuticals & Biotech Breakout Stocks
Results
17
Stocks where the price continues to rise after more than a year of consistent gains.
17 companies
Forte Biosciences
Market Cap: US$1.3b
Operates as a clinical-stage biopharmaceutical company in the United States.
FBRX
US$76.50
7D
61.1%
1Y
557.8%
Anhui Wanbang Pharmaceutical TechnologyLtd
Market Cap: CN¥5.7b
Anhui Wanbang Pharmaceutical Technology Co.,Ltd.
301520
CN¥61.02
7D
30.1%
1Y
76.5%
iX Biopharma
Market Cap: S$560.9m
A specialty pharmaceutical and nutraceutical company, develops, manufactures, and commercializes therapies for the treatment of acute and breakthrough pain, and other health conditions in Singapore, the United States, China, and Australia.
42C
S$0.52
7D
24.1%
1Y
2,352.4%
GlaxoSmithKlineE
Market Cap: ج.م11.9b
Engages in production of pharmaceutical chemicals.
BIOC
ج.م142.80
7D
21.0%
1Y
233.2%
Pyxis Oncology
Market Cap: US$165.4m
A clinical stage company, engages in the development of therapeutics to treat solid tumors.
PYXS
US$2.91
7D
29.3%
1Y
137.6%
Entera Bio
Market Cap: US$101.0m
A clinical stage company, engages in the development of oral peptides and protein replacement therapies in Israel and internationally.
ENTX
US$3.92
7D
97.0%
1Y
90.3%
Cell Source
Market Cap: US$44.2m
A biotechnology company, engages in developing cell therapy treatments based on the management of immune tolerance.
CLCS
US$0.84
7D
31.4%
1Y
110.2%
EOM Pharmaceuticals Holdings
Market Cap: US$26.4m
A clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States.
IMUC
US$0.24
7D
58.6%
1Y
138.1%
Intravenous Infusions
Market Cap: GH₵181.1m
A pharmaceutical company, engages in the manufacturing and marketing of intravenous infusions and small volume injectables for therapeutic purposes in Ghana and the West African sub-region.
IIL
GH₵0.72
7D
56.5%
1Y
1,340.0%
Panacea Life Sciences Holdings
Market Cap: US$4.5m
Operates as a holding company, researchers, develops, manufactures, produces, and distributes cannabinoids, mushrooms, kratom, and other natural, plant-based ingredients and products for humans and animals.
PLSH
US$0.09
7D
20.0%
1Y
177.8%
International Stem Cell
Market Cap: US$2.5m
A clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally.
ISCO
US$0.27
7D
33.3%
1Y
34.5%
Innovation Pharmaceuticals
Market Cap: US$1.4m
A clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective.
IPIX
US$0.0027
7D
35.0%
1Y
800.0%
PAO Group
Market Cap: US$382.0k
Focuses on alternative patient care treatments.
PAOG
US$0.0002
7D
100.0%
1Y
19,900.0%
Cannonau
Market Cap: US$72.5k
Engages in the provision of cannabidiol based products.
CNNC
US$0.0003
7D
50.0%
1Y
200.0%
Statera Biopharma
Market Cap: US$7.3k
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body’s immune system and restore homeostasis.
STAB
US$0.0002
7D
100.0%
1Y
100.0%
eFFECTOR Therapeutics
Market Cap: US$3.8k
A biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer.
EFTR
US$0.0008
7D
60.0%
1Y
33.3%
ObsEva
Market Cap: US$117.0
A biopharmaceutical company, focuses on the development of novel therapies to improve women’s reproductive health.
OBSE.F
US$0.0001
7D
9,900.0%
1Y
0%